US Stocks
/
GRI Bio, Inc. Share Price

GRI Bio, Inc. Share Price

NASDAQ: GRI | Micro Cap
$1.98
-$0.05 (-2.71%) Last updated on 28 Aug, 2026 | 22:50 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

GRI Bio, Inc. Stock Performance

Open
$2.00
Prev. Close
$2.03
Circuit Range
N/A
Day Range
$2.00 - $2.00
Year Range
$0.18 - $6.66
Volume
175
Average Traded
$2.00

GRI Bio, Inc. Share Price Today

As of 29 August 2026, GRI Bio, Inc.'s share price is $1.98. The stock opened at $2.00, compared to its previous close of $2.03. During today's trading session, GRI Bio, Inc.'s share price traded between $2.00 and $2.00, with an average price of $2.00. Over the past 52 weeks, the stock has recorded a high of $6.66 and a low of $0.18. In terms of performance, GRI Bio, Inc.'s share price has declined by 22.55% over the last six months and is up 43.12% on a year-on-year basis.

GRI Bio, Inc. Share Price Chart

$2.00$2.00
L
Show Current Price
H

GRI Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$193869.95
PE Ratio (TTM)
-0.02
Dividend Yield
N/A
EPS (TTM)
$-121.80
Revenue (TTM)
N/A
Return On Equity (TTM)
-199.00%
Profit Margin
N/A
Debt to Equity
0.44
Quarterly Earnings Growth YoY
-58.22%

GRI Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$1.89M-$2.25M-$2.12M-$3.05M-$2.89M-$3.36M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-19.24%5.64%-43.48%5.06%-16.15%

GRI Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$0.00N/AN/AN/AN/A
Net Profit-$9.30M-$7.02M-$13.04M-$8.21M-$11.96M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A24.50%-85.61%37.05%-45.68%

About GRI Bio, Inc.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

GRI Bio, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.45
$2.09
+46.15%
Jul 2026
$1.83
$1.43
-20.99%
Jun 2026
$2.03
$1.81
-12.14%
May 2026
$2.23
$2.06
-8.04%
Apr 2026
$2.39
$2.24
+0.90%
Mar 2026
$2.42
$2.22
-12.94%
Feb 2026
$3.13
$2.55
-21.66%
Jan 2026
$0.24
$3.25
+1,239.51%
Dec 2025
$1.97
$0.24
-87.85%
Nov 2025
$1.66
$2.00
+19.05%
Oct 2025
$2.03
$1.68
-16.83%
Sep 2025
$1.41
$2.02
+46.38%

GRI Share Price FAQs

What is GRI Bio, Inc. share price today?

chevron-up
GRI Bio, Inc. share price today is $1.98 as on August 28, 2026 at 10:50 pm IST.

What is the 52 week high and 52 week low of GRI Bio, Inc. stock?

chevron-up
The 52 week high of GRI Bio, Inc. stock is $6.66, while the 52 week low is $0.18 as of 28 Aug '26.

What is GRI's market capitalisation today?

chevron-up
GRI market capitalisation is $193869.95 as of August 29, 2026, at 6:03 pm IST.

What is GRI's net income for the last quarter?

chevron-up
GRI's net income for the last quarter is -0.00B USD.

What is the 5 year returns of GRI?

chevron-up
The 5 year returns of GRI is -100.00% as on 28 Aug '26.

What is the high & low stock price of GRI today?

chevron-up
GRI stock price hit a high of $2.00 and low of $2.00 as of 28 Aug '26.

Can I buy GRI shares in India?

chevron-up
Yes. You can buy GRI in India by opening an international trading account.